Table 1 Baseline clinical and laboratory characteristics of 107 hypertensive type 2 diabetic patients
From: Hypertension management algorithm for type 2 diabetic patients applied in primary care
Baseline | |
|---|---|
N | 107 |
Age (years) | 62.6 ± 11.2 |
White ethnicity – n (%) | 88 (82.2%) |
Female sex– n (%) | 69 (64.5%) |
Diabetes duration (years) | 8.3 ± 9.2 |
Primary care unit attendance (years) | 2.3 ± 2.7 |
Previous cardiovascular event – n (%) | 21 (19.2%) |
Current Smoking – n (%) | 9 (8.4%) |
SBP (mmHg) | 145.3 ± 21.6 |
DBP (mmHg) | 79.0 ± 11.4 |
BMI (kg/m2) | 30.2 ± 5.9 |
Using statin – n (%) | 47 (44%) |
Using aspirin– n (%) | 66 (61.8%) |
Microalbuminuria– n (%) | 25 (23.4%) |
Diabetes Treatment - n (%) | |
Diet only | 11 (10.3%) |
One agent | 46 (43%) |
Two agents | 42 (39.2) |
Three agents | 8 (7.5%) |
Insulin use | 23 (21.5%) |
Hypertension Treatment | |
No drugs | 11 (10.3%) |
One agent | 28 (26.2%) |
Two agents | 46 (43%) |
Three agents | 16 (15%) |
Four agents | 6 (5.5%) |
Diuretic | 69 |
ACE inhibitor | 76 |
β-blocker | 36 |
Calcium channel blocking | 15 |
Total cholesterol (mg/dl) | 179.9 ± 39.7 |
HDL cholesterol (mg/dl) | 48.0 ± 11.3 |
Triglycerides (mg/dl) | 152 (107.3 -368.7) |
LDL cholesterol (mg/dl) | 100.6 ± 28.4 |
HbA1c (%) | 7.3 ± 1.6 |